Company: TVRD
Filing Date: 2025-02-14
Form Type: S-4/A
Source: 0001104659-25-013053
Chunk: 319

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-02-14
Form: S-4/A
Chunk 319
---
 held by such named executive officer as of January 15, 2025, the latest practicable date before the filing of this proxy statement; and

<div align='center'>180</div>

TABLE OF CONTENTS

• the base salary, target annual incentive compensation, and health and welfare benefit elections of each Cara named executive officer remains the same as of January 15, 2025. The following table and footnotes describe payments and benefits that will be paid solely based on the closing of the Merger (single-trigger payments), and payments and benefits that will be paid based on the closing of the Merger and a qualifying termination of employment following the Merger (double-trigger payments) (in thousands):

| Name             | ​ | ​ | Cash($)(1) |   |       |   | ​ | ​ | Equity($)(2) |   |    |   | ​ | ​ | Perquisites/​Benefits($)(3) |   |     |   | ​ | ​ | Total($) |   |       |   | ​ |
| Chris Posner     | ​ | ​ | ​          | ​ | 2,184 | ​ | ​ | ​ | ​            | ​ | 21 | ​ | ​ | ​ | ​                           | ​ | 183 | ​ | ​ | ​ | ​        | ​ | 2,388 | ​ | ​ |
| Ryan Maynard     | ​ | ​ | ​          | ​ |   860 | ​ | ​ | ​ | ​            | ​ |  0 | ​ | ​ | ​ | ​                           | ​ | 105 | ​ | ​ | ​ | ​        | ​ |   965 | ​ | ​ |
| Scott Terrillion | ​ | ​ | ​          | ​ |   860 | ​ | ​ | ​ | ​            | ​ |  3 | ​ | ​ | ​ | ​                           | ​ | 105 | ​ | ​ | ​ | ​        | ​ |   968 | ​ | ​ |

(1) For Mr. Posner, amount represents installment payments equal to 150% of the sum of Mr. Posner’s current base salary plus a lump sum payment equal to 100% of his target bonus for 2024 and 150% of his target bonus for 2025, which amounts are double trigger payments. For Mr. Maynard and Mr. Terrillion, amount represents installment payments equal to 100% of the sum of their respective current base salary